Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons.
about
HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbiditiesHIV and aging: effects on the central nervous systemHIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional studyHIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment.Cytomegalovirus and HIV: A Dangerous Pas de DeuxDesigner adiponectin receptor agonist stabilizes metabolic function and prevents brain injury caused by HIV protease inhibitorsA Smartphone App to Screen for HIV-Related Neurocognitive ImpairmentPathogenesis of HIV in the central nervous systemCross-sectional study of unexplained white matter lesions in HIV positive individuals undergoing brain magnetic resonance imaging.Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment.HIV-associated neurocognitive disorder.Neurocognitive function in HIV-infected patients: comparison of two methods to define impairmentHost genetic factors predisposing to HIV-associated neurocognitive disorder.Proteinuria is associated with neurocognitive impairment in antiretroviral therapy treated HIV-infected individualsAssociation between latent proviral characteristics and immune activation in antiretrovirus-treated human immunodeficiency virus type 1-infected adultsCentral nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research.Asymptomatic neurocognitive disorders in patients infected by HIV: fact or fiction?Psychological factors, including alexithymia, in the prediction of cardiovascular risk in HIV infected patients: results of a cohort studyHIV, vascular and aging injuries in the brain of clinically stable HIV-infected adults: a (1)H MRS study.Impact of antiretroviral therapy on HIV-related brain injury.HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV researchControversies in HIV-associated neurocognitive disordersImpact of cerebrovascular disease on cognitive function in HIV-infected patients.Raltegravir treatment intensification does not alter cerebrospinal fluid HIV-1 infection or immunoactivation in subjects on suppressive therapyHuman immunodeficiency virus-associated dementia: a link between accumulation of viral proteins and neuronal degeneration.HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment.Brain injury caused by HIV protease inhibitors: role of lipodystrophy and insulin resistance.Diabetes and cognitive decline in a French cohort of patients infected with HIV-1.Cerebrovascular risk factors and brain microstructural abnormalities on diffusion tensor images in HIV-infected individualsBrain and liver pathology, amyloid deposition, and interferon responses among older HIV-positive patients in the late HAART era.Circulating HIV DNA Correlates With Neurocognitive Impairment in Older HIV-infected Adults on Suppressive ARTAssociations of cardiovascular variables and HAART with cognition in middle-aged HIV-infected and uninfected women.Prevention, Rehabilitation, and Mitigation Strategies of Cognitive Deficits in Aging with HIV: Implications for Practice and ResearchImpact of age on markers of HIV-1 diseaseThe aggregate effects of multiple comorbid risk factors on cognition among HIV-infected individualsThe effects of cigarette smoking on learning and memory performance among people living with HIV/AIDS.Health-Related Decision-Making in HIV Disease.Physical exercise is associated with less neurocognitive impairment among HIV-infected adultsDepression and diagnosis of neurocognitive impairment in HIV-positive patients.Anthropometric measures and cognition in middle-aged HIV-infected and uninfected women. The Women's Interagency HIV Study.
P2860
Q27015965-8854AE49-7C2C-4E1A-8872-A7FBD2F149B8Q27025018-6BD91701-31B3-428D-94E0-A986BD129CBEQ28539550-25F506FE-D7A5-40E0-9262-4231E80D8BD5Q30234305-610E61DF-BBE6-484F-8F8B-951F982B844AQ30245376-12A8ADB4-94E7-4CAB-AEC5-9BCA24C1932CQ30625328-941D2A0E-3861-4738-9A54-737F7205120FQ33440991-D5EB0C5E-3D98-4A3E-8756-99AF6BBDA73DQ33781978-8147C6CF-E998-4E60-B025-11825BFC4EBBQ33820078-97E7855B-95EE-40D3-A1EF-F6B023DF686CQ33863368-96C16AEE-C659-4E6A-A98F-BBD8DD1FC728Q33939729-F95BD021-CAE1-4733-AD93-70A990EA11E8Q33982015-19248A09-7794-42E2-B877-E0257E504A79Q34001122-C7BF6718-0A69-4C32-9FC6-B14CDF01C08BQ34048920-2031E41A-2790-4A1F-B0A2-462A5C8B046AQ34057868-E91B5016-B65E-4A96-8583-350E0013DFF5Q34080236-79AD4E98-5B3B-455B-B218-9D1FCCF54DA4Q34113118-0750128A-5EBC-430B-8957-C493D01F4D4CQ34563289-1B6C0B2B-CFFA-4835-B0A0-AC3DB5D30AA8Q34689241-3E56B5E9-CA88-4269-8C6B-B3E9A3A69B49Q34699119-D75DFB60-98BF-4F9E-A7EE-267CFC6873B5Q34721127-EFE6FB23-91A1-442C-AE32-64510896D43EQ35037015-AFDF5683-A052-44F3-AAC2-6609E41F8787Q35178171-8BB11CE8-04F6-4EBE-B2B7-0E3964303B2CQ35532868-BB0A3D2D-6E0A-45D5-986D-4C434E73F812Q35702700-DFD91364-A79A-423B-A43A-4B459BF35038Q36009246-8C49FC78-C34E-4818-81DF-295BF46708A6Q36104280-4714E567-7A2C-4F9C-8105-322E977467F2Q36155683-EB6F6F4D-C853-4F0C-83FD-DBD3886AC822Q36169866-92479C81-603F-463C-B1EB-F575F92A4B26Q36284359-0E1BAAB0-4837-4493-83D1-A7748519859BQ36316590-B24C139A-ABB5-478F-9453-C5C3C86CF657Q36433552-774E053B-1406-4395-B621-E70EF2DB0F7CQ36616443-6F57E00D-D99E-4F39-BDE2-400E53F64D77Q36763762-E9162350-9ED9-4F37-8747-0864B965A452Q36810375-B5339BD2-C854-4A94-88D7-38D9395BDD57Q36901835-4F8C1A38-F1D3-4A5A-B17A-6C3633655C0CQ36931956-FA3B191C-3D88-4767-A515-F93FBC3E0DB7Q37227851-40F12EBE-125C-4096-8D6E-1A04D6FDDC7AQ37272196-C20E3AA6-35D4-4B2B-9978-5BA72E7A8488Q37643066-838E6472-E7B0-4FE8-AF8C-96164F4F52A8
P2860
Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cardiovascular risk factors as ...... mance in HIV-positive persons.
@ast
Cardiovascular risk factors as ...... mance in HIV-positive persons.
@en
Cardiovascular risk factors as ...... mance in HIV-positive persons.
@nl
type
label
Cardiovascular risk factors as ...... mance in HIV-positive persons.
@ast
Cardiovascular risk factors as ...... mance in HIV-positive persons.
@en
Cardiovascular risk factors as ...... mance in HIV-positive persons.
@nl
prefLabel
Cardiovascular risk factors as ...... mance in HIV-positive persons.
@ast
Cardiovascular risk factors as ...... mance in HIV-positive persons.
@en
Cardiovascular risk factors as ...... mance in HIV-positive persons.
@nl
P2093
P2860
P1433
P1476
Cardiovascular risk factors as ...... rmance in HIV-positive persons
@en
P2093
A C Penalva de Oliveira
E J Wright
F Drummond
INSIGHT SMART Study Group
K Robertson
M J Vjecha
P2860
P304
P356
10.1212/WNL.0B013E3181F11BD8
P407
P50
P577
2010-08-11T00:00:00Z